Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study
- Resource Type
- Article
- Source
- The Lancet Gastroenterology & Hepatology; January 2022, Vol. 7 Issue: 1 p28-37, 10p
- Subject
- Language
- ISSN
- 24681253